Lehrstuhl für Innere Medizin I (Medizin 1)

Targeting Immune Cell Wiring in Ulcerative Colitis (2019) Neurath M, Chiriac MT Journal article Deletion of the Casp8 gene in mice results in ileocolitis, gut barrier dysfunction, and malassimilation, which can be partially attenuated by inulin or sodium butyrate. (2019) Günther C, Kaden-Volynets V, Zimmermann J, Beisner J, Becker C, Bischoff SC Journal article Erratum: August 2019 - AWMF-Registriernummer: 021-009 (Zeitschrift fur Gastroenterologie (2019) 57 (1321-1405) DOI: 10.1055/a-1015-7265) Erratum: Aktualisierte S3-Leitlinie Colitis ulcerosa (Zeitschrift fur Gastroenterologie (2019) 57 (1321-1405) DOI: 10.1055/a-1015-7265) (2019) Kucharzik T, Dignass AU, Atreya R, Bokemeyer B, Esters P, Herrlinger K, Kannengieβer K, et al. Journal article, Erratum Resolution of inflammation: from basic concepts to clinical application (2019) Neurath M Journal article Aktualisierte S3-Leitlinie Colitis ulcerosa (2019) Kucharzik T, Dignass AU, Atreya R, Bokemeyer B, Esters P, Herrlinger K, Kannengießer K, et al. Journal article IFN-γ drives inflammatory bowel disease pathogenesis through VE-cadherin-directed vascular barrier disruption (2019) Langer V, Vivi E, Regensburger D, Winkler T, Waldner M, Rath T, Schmid B, et al. Journal article, Original article Interferon Lambda Promotes Paneth Cell Death Via STAT1 Signaling in Mice and Is Increased in Inflamed Ileal Tissues of Patients With Crohn's Disease (2019) Günther C, Ruder B, Stolzer I, Dorner H, He GW, Aden K, Strigli A, et al. Journal article Inhibiting PGGT1B Disrupts Function of RHOA, Resulting in T-cell Expression of Integrin α4β7 and Development of Colitis in Mice (2019) Lopez Posadas R, Fastancz P, Martínez-Sánchez LdC, Panteleev-Ivlev J, Thonn V, Kisseleva T, Becker LS, et al. Journal article, Original article Resolution of acute intestinal graft-versus-host disease (2019) Thiagarajan S, Neurath M, Hildner K Journal article, Review article Early Symptom Improvement With Risankizumab Treatment in Patients With Moderately to Severely Active Crohn's Disease: Analysis From a Phase 2 Study (2019) Feagan BG, Sandborn WJ, D'Haens GR, Panes J, Kaser A, Ferrante M, Louis E, et al. Conference contribution